Search details
1.
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Blood
; 2024 05 16.
Article
in English
| MEDLINE | ID: mdl-38754055
2.
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Blood
; 142(17): 1438-1447, 2023 10 26.
Article
in English
| MEDLINE | ID: mdl-37418685
3.
Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse.
Blood
; 140(17): 1907-1916, 2022 10 27.
Article
in English
| MEDLINE | ID: mdl-35789260
4.
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.
Eur J Nucl Med Mol Imaging
; 2024 May 25.
Article
in English
| MEDLINE | ID: mdl-38795120
5.
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
Br J Haematol
; 201(4): 653-662, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36733229
6.
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Haematologica
; 108(4): 1083-1091, 2023 04 01.
Article
in English
| MEDLINE | ID: mdl-36384247
7.
High rate of durable responses with undetectable minimal residual disease with front-line venetoclax and rituximab in young, fit patients with chronic lymphocytic leukemia and an adverse biological profile: results of the GIMEMA phase II LLC1518 - VERITAS study.
Haematologica
; 108(8): 2091-2100, 2023 08 01.
Article
in English
| MEDLINE | ID: mdl-36632738
8.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Hematol Oncol
; 41(1): 78-87, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36177902
9.
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
Hematol Oncol
; 40(1): 31-39, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34694649
10.
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.
Hematol Oncol
; 38(3): 257-265, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-32356913
11.
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.
Oncologist
; 24(8): e720-e729, 2019 08.
Article
in English
| MEDLINE | ID: mdl-30552159
12.
The metronomic all-oral DEVEC is an effective schedule in elderly patients with diffuse large b-cell lymphoma.
Invest New Drugs
; 37(3): 548-558, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31028663
13.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica
; 102(11): 1931-1935, 2017 11.
Article
in English
| MEDLINE | ID: mdl-28775121
14.
Prognostic roles of absolute monocyte and absolute lymphocyte counts in patients with advanced-stage follicular lymphoma in the rituximab era: an analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.
Br J Haematol
; 169(4): 544-51, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25817296
15.
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
Br J Haematol
; 185(5): 940-944, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30407625
16.
Aggressive lymphomas of the elderly: the DEVEC metronomic chemotherapy schedule fits the unfit.
Br J Haematol
; 183(5): 819-822, 2018 12.
Article
in English
| MEDLINE | ID: mdl-29193017
17.
New treatment options in elderly patients with Diffuse Large B-cell Lymphoma.
Front Oncol
; 13: 1214026, 2023.
Article
in English
| MEDLINE | ID: mdl-37465115
18.
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL.
Blood Adv
; 7(15): 3916-3924, 2023 08 08.
Article
in English
| MEDLINE | ID: mdl-37171620
19.
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma.
Blood Adv
; 7(15): 4160-4169, 2023 08 08.
Article
in English
| MEDLINE | ID: mdl-37276080
20.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Leukemia
; 37(2): 433-440, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36653509